Pasola, Rogelio, Jr. L.

HRN: 29-48-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2026
CEFTAZIDIME 1GM (VIAL)
08/14/2026
08/21/2026
IV
2g
Q8
Cap Mr
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines